Maternal serum adiponectin concentration in gestational diabetes

Gynecological Endocrinology

Volumn 25, Issue 9, 2009, Pages 593-596

  Soheilykhah, Sedigheh ^a   Mohammadi, Mohammad ^a   Mojibian, Mahdieh ^a   Rahimi Saghand, Soodabeh ^a   Rashidi, Maryam ^a   Hadinedoushan, Hossein ^a   Afkhami Ardekani, Mohammad ^a  

^a Yazd Diabetes Research Center   (Iran)

Author keywords

Adiponectin; Body mass index; Gestational diabetes; Glucose tolerance test; Neonatal weight

Indexed keywords

ADIPONECTIN; INSULIN;

ADULT; ARTICLE; BIRTH WEIGHT; BODY MASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GESTATIONAL AGE; GLUCOSE TOLERANCE TEST; GROUPS BY AGE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MATERNAL SERUM; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL;

ADIPONECTIN; ADULT; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; PREGNANCY;

EID: 70350656288     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590902972109     Document Type: Article

References (21)

1. Metzger BE, Coustan DR. The Organizing Committee: summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 1998;21(Suppl 2):B161-B167.
2. Sepe SJ, Connell FA, Geiss LS, Teutsch SM. Gestational diabetes: incidence, maternal characteristics, and perinatal outcome. Diabetes 1985;34(Suppl 2):13-16.
3. Weeks JW,Major CA, de Veciana M, Morgan MA. Gestational diabetes: does the presence of risk factors influence perinatal outcome? Am J Obstet Gynecol 1994;171:1003-1007.
4. Homko CJ, Sivan E, Reece EA, Boden G. Fuel metabolism during pregnancy. Semin Reprod Endocrinol 1999;17:119-125.
5. Linne Y, Barkeling B, Rossner S. Natural course of gestational diabetes mellitus: long term follow up of women in the SPAWN study. BJOG 2002;109:1227-1231.
6. Kjos SI, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA. Predicting future diabetes in Latino women with gestational diabetes: utility of the early postpartum glucose tolerance testing. Diabetes 1995;44:586-591.
7. Díez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003;148:293-300.
8. Havel PJ. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004; 53(Suppl 1):S143-S151.
9. Arita Y, Kihara S, Ouchi N. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Comm 2000;257:79-83.
10. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care 2004;27:S88-S90.
11. Jovanovic L. American Diabetes Association's Fourth International Workshop-Conference on Gestational Diabetes Mellitus: summary and discussion. Therapeutic intervention. Diabetes Care 1998;21(Suppl 2):B131-137.
12. Maghbooli ZH, Hossein-nezhad A, Karimi F, Shafaei AR, Larijani B. Correlation between vitamin D3 deficiency and insulin resistance in pregnancy. Diabetes Metab Res Rev 2008;24:27-32.
13. Tsai PJ, Yu CH, Hsu SP, Lee YH, Huang IT, Ho SC, Chu CH. Maternal plasma adiponectin concentrations at 24 to 31 weeks of gestation: negative association with gestational diabetes mellitus. Nutrition 2005;21:1095-1099.
14. Worda C, Leipold H, Gruber Ch, Kautzky-Willer A, Knöfler M, Bancher-Todesca D. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. Am J Obstet Gynecol 2004;191:2120-2124.
15. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectimia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. Clin Endocrinol Metab J 2001;86:1930-1935.
16. Kjos SL, Buchanan TA. Gestational diabetes mellitus. N Engl J Med 1999;341:1749-1756.
17. Retnakaran R, Hanley AJG, Raif N, Hirning CR, Connelly PW, Sermer M, Kahn SE, Zinman B. Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia 2005;48:993-1001.
18. Retnakaran R, Hanley AJG, Raif N, Hirning CR, Connelly PW, Sermer M, Kahn SE, Zinman B. Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 2004; 27:799-800.
19. Vitoratos N, Deliveliotou A, Vlahos N, Mastorakos G, Papadias K, Botsis D, Creatsas GK. Serum adiponectin during pregnancy and post partum in women with gestational diabetes and normal control. Gynecol Endocrinol 2008;24: 614-619.
20. Cseh K, Baranyl E, Melczer Z. Plasma adiponectin and pregnancy induced insulin resistance. Diabetes Care 2004;27: 274-275.
21. Chan TF, Yuan SS, Chen HS, Guu CF, Wu LC, Yeh YT, Chung YF, Jong SB, Su JH. Correlations between umbilical and maternal serum adiponectin levels and neonatal birthweights. Acta Obstet Gynecol Scand 2004;83:165-169.